Clinical Trials Logo

Clinical Trial Summary

A multinational, prospective and observational study that will assess the management of ACS in real-life practices in Middle East North Africa area.


Clinical Trial Description

The aim of this Middle Eastern and African study is to describe the short- and long-term (i.e. up to 3 years following the index event) management in patients hospitalized for an Acute Coronary Syndrome and pharmacological management patterns in a 'real-life' setting. The TOURACO observational study will include not only hospitals with cardiac intervention facilities but also regional and community-type hospitals that have limited (if at all) cardiac intervention facilities. The treatments prescription will be left to the investigator discretion, and will be used in accordance with the local label of each country. Off-label medication is not authorized in TOURACO study. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03362463
Study type Observational
Source AstraZeneca
Contact
Status Completed
Phase
Start date December 28, 2015
Completion date April 2, 2020

See also
  Status Clinical Trial Phase
Completed NCT02587481 - Pneumological Acute Coronary Syndrom (ACS) Phenotyping Aachen N/A